7,496.08

-53.86

-0.71%

52,211.48

-178.27

-0.34%

24,997.59

-255.55

-1.01%

2,840.81

+86.71

+3.15%

4.9580

+0.0940

+1.93%

21.06

+1.14

+5.72%

4,064.80

-49.70

-1.21%

73,633.91

-1,153.59

-1.54%

Crude Oil Dec 26

84.47

-2.38

-2.74%

US Private Equity

10,850.15

0.00

0.00%

NasdaqCM - Nasdaq Real Time Price USD

Firefly Neuroscience, Inc. (AIFF)

0.9500 +0.0014 (+0.15%)

As of 9:30:01 AM EST. Market Open.

Loading Chart for AIFF

Chart Range Bar

Interval:

In partnership with ChartIQ

Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today

BC-Most Active Stocks

BC-Most Active Stocks

Firefly Confirms Public-Private Partnership with the Department of War

Firefly Confirms Public-Private Partnership with the Department of War

BC-Most Active Stocks

BC-Most Active Stocks

Mobilize your Website

View Site in Mobile | Classic

Share by: